How much profit has Medifast made this year?
Medifast has made 19.56 M USD this year.
Medifast Net Income 2024
Medifast Net Income
19.56 M USD
Ticker
MED
ISIN
US58470H1014
WKN
889384
In 2024, Medifast's profit amounted to 19.56 M USD, a -80.33% increase from the 99.42 M USD profit recorded in the previous year.
The Medifast Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2026e | 5.52 |
| 2025e | 3.31 |
| 2024e | 19.56 |
| 2023 | 99.42 |
| 2022 | 143.6 |
| 2021 | 164 |
| 2020 | 102.9 |
| 2019 | 77.9 |
| 2018 | 55.8 |
| 2017 | 27.7 |
| 2016 | 17.8 |
| 2015 | 20.1 |
| 2014 | 13.2 |
| 2013 | 24 |
| 2012 | 15.9 |
| 2011 | 18.5 |
| 2010 | 19.6 |
| 2009 | 11.4 |
| 2008 | 4.3 |
| 2007 | 3.4 |
| 2006 | 5.2 |
| 2005 | 2.1 |
| 2004 | 1.7 |
Medifast Revenue, EBIT, Net Income US58470H1014 · 889384
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Medifast, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Medifast from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Medifast’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Medifast. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Medifast’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Medifast’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Medifast’s growth potential.
Medifast Revenue, EBIT and net profit per share
| Date | Medifast Revenue | Medifast EBIT | Medifast Net Income |
|---|---|---|---|
| 2026e | 514.29 M undefined | 2.02 M undefined | 5.52 M undefined |
| 2025e | 514.95 M undefined | -808,000 undefined | 3.31 M undefined |
| 2024e | 603.68 M undefined | 21.92 M undefined | 19.56 M undefined |
| 2023 | 1.07 B undefined | 126.4 M undefined | 99.42 M undefined |
| 2022 | 1.6 B undefined | 184.8 M undefined | 143.6 M undefined |
| 2021 | 1.53 B undefined | 216.2 M undefined | 164 M undefined |
| 2020 | 934.8 M undefined | 141.2 M undefined | 102.9 M undefined |
| 2019 | 713.7 M undefined | 91 M undefined | 77.9 M undefined |
| 2018 | 501 M undefined | 69.1 M undefined | 55.8 M undefined |
| 2017 | 301.6 M undefined | 39.6 M undefined | 27.7 M undefined |
| 2016 | 274.5 M undefined | 26.9 M undefined | 17.8 M undefined |
| 2015 | 272.8 M undefined | 28.7 M undefined | 20.1 M undefined |
| 2014 | 285.3 M undefined | 30.2 M undefined | 13.2 M undefined |
| 2013 | 324.1 M undefined | 38.4 M undefined | 24 M undefined |
| 2012 | 318.6 M undefined | 27.1 M undefined | 15.9 M undefined |
| 2011 | 298.2 M undefined | 27.4 M undefined | 18.5 M undefined |
| 2010 | 257.6 M undefined | 31.6 M undefined | 19.6 M undefined |
| 2009 | 169.7 M undefined | 18.5 M undefined | 11.4 M undefined |
| 2008 | 110.1 M undefined | 7.4 M undefined | 4.3 M undefined |
| 2007 | 83.8 M undefined | 5.7 M undefined | 3.4 M undefined |
| 2006 | 74.1 M undefined | 7.4 M undefined | 5.2 M undefined |
| 2005 | 40.1 M undefined | 3.5 M undefined | 2.1 M undefined |
| 2004 | 27.3 M undefined | 3 M undefined | 1.7 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 27.3 M USD | 3 M USD | 1.7 M USD |
| 2005 | 40.1 M USD | 3.5 M USD | 2.1 M USD |
| 2006 | 74.1 M USD | 7.4 M USD | 5.2 M USD |
| 2007 | 83.8 M USD | 5.7 M USD | 3.4 M USD |
| 2008 | 110.1 M USD | 7.4 M USD | 4.3 M USD |
| 2009 | 169.7 M USD | 18.5 M USD | 11.4 M USD |
| 2010 | 257.6 M USD | 31.6 M USD | 19.6 M USD |
| 2011 | 298.2 M USD | 27.4 M USD | 18.5 M USD |
| 2012 | 318.6 M USD | 27.1 M USD | 15.9 M USD |
| 2013 | 324.1 M USD | 38.4 M USD | 24 M USD |
| 2014 | 285.3 M USD | 30.2 M USD | 13.2 M USD |
| 2015 | 272.8 M USD | 28.7 M USD | 20.1 M USD |
| 2016 | 274.5 M USD | 26.9 M USD | 17.8 M USD |
| 2017 | 301.6 M USD | 39.6 M USD | 27.7 M USD |
| 2018 | 501 M USD | 69.1 M USD | 55.8 M USD |
| 2019 | 713.7 M USD | 91 M USD | 77.9 M USD |
| 2020 | 934.8 M USD | 141.2 M USD | 102.9 M USD |
| 2021 | 1.53 B USD | 216.2 M USD | 164 M USD |
| 2022 | 1.6 B USD | 184.8 M USD | 143.6 M USD |
| 2023 | 1.07 B USD | 126.4 M USD | 99.42 M USD |
| 2024e | 603.68 M USD | 21.92 M USD | 19.56 M USD |
| 2025e | 514.95 M USD | -808,000 USD | 3.31 M USD |
| 2026e | 514.29 M USD | 2.02 M USD | 5.52 M USD |
Medifast stock margins US58470H1014 · 889384
The Medifast margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Medifast. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Medifast.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Medifast's sales revenue. A higher gross margin percentage indicates that the Medifast retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Medifast's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Medifast's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Medifast's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Medifast. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Medifast's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Medifast Margin History
| Medifast Gross margin | Medifast Profit margin | Medifast EBIT margin | Medifast Profit margin |
|---|---|---|---|
| 2026e | 72.37 % | 0.39 % | 1.07 % |
| 2025e | 72.37 % | -0.16 % | 0.64 % |
| 2024e | 72.37 % | 3.63 % | 3.24 % |
| 2023 | 72.37 % | 11.79 % | 9.27 % |
| 2022 | 71.34 % | 11.56 % | 8.98 % |
| 2021 | 73.89 % | 14.17 % | 10.75 % |
| 2020 | 74.65 % | 15.1 % | 11.01 % |
| 2019 | 75.23 % | 12.75 % | 10.91 % |
| 2018 | 75.83 % | 13.79 % | 11.14 % |
| 2017 | 75.53 % | 13.13 % | 9.18 % |
| 2016 | 74.94 % | 9.8 % | 6.48 % |
| 2015 | 73.79 % | 10.52 % | 7.37 % |
| 2014 | 73.33 % | 10.59 % | 4.63 % |
| 2013 | 74.24 % | 11.85 % | 7.41 % |
| 2012 | 74.04 % | 8.51 % | 4.99 % |
| 2011 | 75.29 % | 9.19 % | 6.2 % |
| 2010 | 74.73 % | 12.27 % | 7.61 % |
| 2009 | 73.31 % | 10.9 % | 6.72 % |
| 2008 | 71.84 % | 6.72 % | 3.91 % |
| 2007 | 74.34 % | 6.8 % | 4.06 % |
| 2006 | 75.3 % | 9.99 % | 7.02 % |
| 2005 | 74.81 % | 8.73 % | 5.24 % |
| 2004 | 75.46 % | 10.99 % | 6.23 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 75.46 % | 10.99 % | 6.23 % |
| 2005 | 74.81 % | 8.73 % | 5.24 % |
| 2006 | 75.3 % | 9.99 % | 7.02 % |
| 2007 | 74.34 % | 6.8 % | 4.06 % |
| 2008 | 71.84 % | 6.72 % | 3.91 % |
| 2009 | 73.31 % | 10.9 % | 6.72 % |
| 2010 | 74.73 % | 12.27 % | 7.61 % |
| 2011 | 75.29 % | 9.19 % | 6.2 % |
| 2012 | 74.04 % | 8.51 % | 4.99 % |
| 2013 | 74.24 % | 11.85 % | 7.41 % |
| 2014 | 73.33 % | 10.59 % | 4.63 % |
| 2015 | 73.79 % | 10.52 % | 7.37 % |
| 2016 | 74.94 % | 9.8 % | 6.48 % |
| 2017 | 75.53 % | 13.13 % | 9.18 % |
| 2018 | 75.83 % | 13.79 % | 11.14 % |
| 2019 | 75.23 % | 12.75 % | 10.91 % |
| 2020 | 74.65 % | 15.1 % | 11.01 % |
| 2021 | 73.89 % | 14.17 % | 10.75 % |
| 2022 | 71.34 % | 11.56 % | 8.98 % |
| 2023 | 72.37 % | 11.79 % | 9.27 % |
| 2024e | 72.37 % | 3.63 % | 3.24 % |
| 2025e | 72.37 % | -0.16 % | 0.64 % |
| 2026e | 72.37 % | 0.39 % | 1.07 % |
Medifast Aktienanalyse
What does Medifast do?
Medifast Inc. is a leading provider of health and wellness solutions, with its headquarters in Baltimore, Maryland. The company was founded in 1980 by Dr. William Vitale and has since experienced continuous growth. Medifast's nutrition and health products are available in the United States, Canada, and Puerto Rico. Medifast ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Medifast's Profit Margins
The profit margins of Medifast represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Medifast's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Medifast's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Medifast's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Medifast’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Medifast stock
How has the profit developed compared to last year?
The profit has increased by -80.33% compared to last year fallen
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Medifast publish its earnings?
Medifast publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Medifast?
The profits of Medifast are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Medifast?
You can learn more about the earnings of Medifast by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Medifast pay?
Over the past 12 months, Medifast paid a dividend of 4.95 USD . This corresponds to a dividend yield of about 25.08 %. For the coming 12 months, Medifast is expected to pay a dividend of 7.29 USD.
What is the dividend yield of Medifast?
The current dividend yield of Medifast is 25.08 %.
When does Medifast pay dividends?
Medifast pays a quarterly dividend. This is distributed in the months of January, April, July, October.
How secure is the dividend of Medifast?
Medifast paid dividends every year for the past 12 years.
What is the dividend of Medifast?
For the upcoming 12 months, dividends amounting to 7.29 USD are expected. This corresponds to a dividend yield of 36.93 %.
In which sector is Medifast located?
Medifast is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Medifast kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Medifast from 11/7/2023 amounting to 1.65 USD, you needed to have the stock in your portfolio before the ex-date on 9/18/2023.
When did Medifast pay the last dividend?
The last dividend was paid out on 11/7/2023.
What was the dividend of Medifast in the year 2023?
In the year 2023, Medifast distributed 6.56 USD as dividends.
In which currency does Medifast pay out the dividend?
The dividends of Medifast are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Medifast stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Medifast
Our stock analysis for Medifast Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medifast Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
